Monaco
Evome Medical Technologies Inc (LNDZF) Q2 2024 Earnings Call Transcript Highlights: Strong Revenue Growth and Debt Reduction
Revenue: $10.5 million for Q2 2024.Core Business Revenue (Biodex Rehab): $6.1 million.Revenue Growth: 59% increase over Q1 2024.Gross Profit: $3.3 million.Core